Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guang Sun

Showing results (611-620 of 624) with videos related to

Pageof 63
Sort By:
Journal of Advanced Research|July 27, 2023
Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagyJia-Jie Lin, Rui Chen, Li-Yun Yang, et al.
Nature Communications|November 21, 2019
Genome-wide analysis of Cushion willow provides insights into alpine plant divergence in a biodiversity hotspotJia-Hui Chen, Yuan Huang, Benjamin Brachi, et al.
Metabolites|April 21, 2022
Restricting Branched-Chain Amino Acids within a High-Fat Diet Prevents ObesityMing Liu, Yiheng Huang, Hongwei Zhang, et al.
Human Vaccines & Immunotherapeutics|July 14, 2022
Safety and immunogenicity of an <i>Escherichia coli</i>-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trialZhao-Jun Mo, Zhao-Feng Bi, Wei Sheng, et al.
Schizophrenia Bulletin|March 19, 2020
Cognitive Enhancing Effect of High-Frequency Neuronavigated rTMS in Chronic Schizophrenia Patients With Predominant Negative Symptoms: A Double-Blind Controlled 32-Week Follow-up StudyMei Hong Xiu, Heng Yong Guan, Jian Min Zhao, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of an Kai Chu, Zhao-Feng Bi, Wei-Jin Huang, et al.
Translational Psychiatry|February 27, 2020
High-frequency neuronavigated rTMS effect on clinical symptoms and cognitive dysfunction: a pilot double-blind, randomized controlled study in Veterans with schizophreniaHeng Yong Guan, Jian Min Zhao, Ke Qiang Wang, et al.
The Lancet. Infectious Diseases|July 20, 2023
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trialFeng-Cai Zhu, Guo-Hua Zhong, Wei-Jin Huang, et al.
Nature Communications|July 26, 2018
In-orbit operation of an atomic clock based on laser-cooled <sup>87</sup>Rb atomsLiang Liu, De-Sheng Lü, Wei-Biao Chen, et al.
Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
Pageof 63

Showing results (611-620 of 624) with videos related to

Sort By:
Pageof 63
Journal of Advanced Research|July 27, 2023
Hsa_circ_0001402 alleviates vascular neointimal hyperplasia through a miR-183-5p-dependent regulation of vascular smooth muscle cell proliferation, migration, and autophagyJia-Jie Lin, Rui Chen, Li-Yun Yang, et al.
Nature Communications|November 21, 2019
Genome-wide analysis of Cushion willow provides insights into alpine plant divergence in a biodiversity hotspotJia-Hui Chen, Yuan Huang, Benjamin Brachi, et al.
Metabolites|April 21, 2022
Restricting Branched-Chain Amino Acids within a High-Fat Diet Prevents ObesityMing Liu, Yiheng Huang, Hongwei Zhang, et al.
Human Vaccines & Immunotherapeutics|July 14, 2022
Safety and immunogenicity of an <i>Escherichia coli</i>-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trialZhao-Jun Mo, Zhao-Feng Bi, Wei Sheng, et al.
Schizophrenia Bulletin|March 19, 2020
Cognitive Enhancing Effect of High-Frequency Neuronavigated rTMS in Chronic Schizophrenia Patients With Predominant Negative Symptoms: A Double-Blind Controlled 32-Week Follow-up StudyMei Hong Xiu, Heng Yong Guan, Jian Min Zhao, et al.
The Lancet Regional Health. Western Pacific|June 7, 2023
Safety and immunogenicity of an Kai Chu, Zhao-Feng Bi, Wei-Jin Huang, et al.
Translational Psychiatry|February 27, 2020
High-frequency neuronavigated rTMS effect on clinical symptoms and cognitive dysfunction: a pilot double-blind, randomized controlled study in Veterans with schizophreniaHeng Yong Guan, Jian Min Zhao, Ke Qiang Wang, et al.
The Lancet. Infectious Diseases|July 20, 2023
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trialFeng-Cai Zhu, Guo-Hua Zhong, Wei-Jin Huang, et al.
Nature Communications|July 26, 2018
In-orbit operation of an atomic clock based on laser-cooled <sup>87</sup>Rb atomsLiang Liu, De-Sheng Lü, Wei-Biao Chen, et al.
Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
Pageof 63